Drug details

Fulyzaq (crofelemer delayed-release tablets)

type of

Fulyzaq (crofelemer) is an antidiarrheal medication used to treat and relieve symptoms of non-infectious diarrhea in HIV/AIDS patients taking antiretroviral therapy.

The drug is often used to treat HIV .

This drug may have the following side effects:

• cough
• nausea
• muscle pain
• back pain
• bloating
• runny or stuffy nose
• joint pain
• bronchitis
• hemorrhoids
• upper respiratory tract infections
• flatulence (gas)
• urinary tract infection
• anxiety, and

The following drugs are related to Fulyzaq, either as a replacement or used together:

• Epzicom (abacavir sulfate and lamivudine tablets)
• Trizivir (abacavir sulfate, lamivudine, and zidovudine)
• Reyataz (atazanavir sulfate)
• Crixivan (indinavir sulfate)
• Prezista (darunavir)
• Rescriptor (delavirdine mesylate)
• Videx EC (didanosine delayed-release capsules)
• Videx (didanosine pediatric powder for oral solution)
• Sustiva (efavirenz)
• Genvoya (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide tablets)
• Emtriva (emtricitabine)
• Fuzeon (enfuvirtide)
• Epivir (lamivudine)
• Isentress (raltegravir tablets)
• Viramune (nevirapine)
• Viramune XR (nevirapine extended-release tablets, for oral use)